Additional file 1 of Quality-of-life measures and their psychometric properties used in African chronic kidney disease populations: a systematic review using COSMIN methodology

Supplementary file 1: Additional file 1. PRISMA 2020 for Abstracts Checklist. Additional file 2. PRISMA checklist. Additional file 3. Search equations

Distributions of items and latent variable for and .

<p>Vertical lines: values of the difficulties of the items.</p

Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule: a multicentre study in 18 French districts-0

Aspiration biopsy; Wang: Wang needle biopsy; SUR: surgery; CRT: chemoradiotherapy).<p><b>Copyright information:</b></p><p>Taken from "Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule: a multicentre study in 18 French districts"</p><p>http://www.biomedcentral.com/1471-2407/8/93</p><p>BMC Cancer 2008;8():93-93.</p><p>Published online 10 Apr 2008</p><p>PMCID:PMC2373300.</p><p></p

Survival curves for expanded disability status scale (EDSS) scores 3 (A) and 6 (B) of patients.

<p>First generation North Africans (NA1G), second generation North Africans (NA2G) and Europeans (E).</p

Association between “origin/generation” and assignment to expanded disability status scale (EDSS) scores 3 and 6.

<p>Association between “origin/generation” and assignment to expanded disability status scale (EDSS) scores 3 and 6.</p

Annual costs over the 4-year follow-up by resource component.

1<p>Physician visit costs used were the following: 28.27€ for rheumatologists, 28.61€ for internists, 22.13€ for general practitioners and 30.56€ for orthopaedist surgeons.</p>2<p>Health professional consultation costs used were the following: 11.30 € for nurses, 16.32 € for physiotherapists, 40.82 € for psychologists and 14.90 € for occupational therapists.</p>3<p>Lab test costs used were the following: 173.80 € for inclusion biologic investigations, 28.86 € for monthly biologic tests and 42.63 € for annual biologic tests.</p>4<p>Imaging and other devices costs included the following: 19.95 to 39.95 € for X-ray depending on the number of X-rays (19.95 € for the 1st X-ray, 39.95 € for the 2nd, 21.28 € for the 3rd, 20.00 € for the 4th), 69.00 € for MRI, 25.27 € for CT-scanner, 96.00 € for gastric endoscopy and 204.18 € for colonoscopy.</p>5<p>Transportation costs were calculated on the basis of a reimbursement fee of 1.17 € per km.</p>6<p>Inpatient costs were based on DRG tariffs.</p><p>DMARD = Disease-modifying antirheumatic drugs.</p

Mean costs per period according to treatment strategy.

<p>(A) Mean total costs according to treatment strategy; (B) Mean other health resource use costs according to treatment strategy.</p

Multivariate analysis of the effects of demographic and clinical variables and treatment strategy on total costs over 4 years.

<p>The reported Rate Ratios describe the variations in costs expressed as a multiplicative factor for patients presenting the associated characteristic compared to those who did not, all other things being equal.</p><p>MCMC = Markov Chain Monte Carlo; CI = Confidence Intervalle; HAQ = Health Assessment Questionnaire; RA = Rheumatoid Arthritis; ICC = Intraclass Correlation Coefficient.</p>1<p>Median and range for all 24 imputed datasets.</p

Baseline patient characteristics.

<p>Values are mean values (SD) or number of patients (%).</p>1<p>Eular Guideline: 1st rheumatologist visit after RA onset <45 days; ESR = Erythrocyte sedimentation rate, CRP = C-Reactive Protein, DAS-28 = Disease Activity Score 28, HAQ = Health Assessment Questionnaire, ACR = American College of Rheumatology, VAS = Visual analogue scale, EULAR = European League Against Rheumatism, DMARD = Disease-modifying antirheumatic drug, ACPA = anti-citrullinated protein antibody.</p

Multivariate analysis of the effects of demographic and clinical variables and treatment strategy on other health resource use costs over 4 years.

<p>The reported Rate Ratios describe the variations in costs expressed as a multiplicative factor for patients presenting the associated characteristic compared to those who did not, all other things being equal.</p><p>MCMC = Markov Chain Monte Carlo; CI = Confidence Intervalle; HAQ = Health Assessment Questionnaire; RA = Rheumatoid Arthritis; ICC = Intraclass Correlation Coefficient.</p>1<p>Median and range for all 24 imputed datasets<b>.</b></p